Scientific barriers to developing vaccines against avian influenza viruses
Identifieur interne : 001422 ( Main/Exploration ); précédent : 001421; suivant : 001423Scientific barriers to developing vaccines against avian influenza viruses
Auteurs : Kanta Subbarao [États-Unis] ; Tomy Joseph [États-Unis]Source :
- Nature Reviews Immunology [ 1474-1733 ] ; 2007-04.
Abstract
The increasing number of reports of direct transmission of avian influenza viruses to humans underscores the need for control strategies to prevent an influenza pandemic. Vaccination is the key strategy to prevent severe illness and death from pandemic influenza. Despite long-term experience with vaccines against human influenza viruses, researchers face several additional challenges in developing human vaccines against avian influenza viruses. In this Review, we discuss the features of avian influenza viruses, the gaps in our understanding of infections caused by these viruses in humans and of the immune response to them that distinguishes them from human influenza viruses, and the current status of vaccine development.
Url:
- https://api.istex.fr/ark:/67375/GT4-CGS590CN-8/fulltext.pdf
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097526
DOI: 10.1038/nri2054
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000761
- to stream Istex, to step Curation: 000761
- to stream Istex, to step Checkpoint: 000405
- to stream Pmc, to step Corpus: 000240
- to stream Pmc, to step Curation: 000240
- to stream Pmc, to step Checkpoint: 000B45
- to stream Ncbi, to step Merge: 000215
- to stream Ncbi, to step Curation: 000215
- to stream Ncbi, to step Checkpoint: 000215
- to stream Main, to step Merge: 001440
- to stream Main, to step Curation: 001422
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Scientific barriers to developing vaccines against avian influenza viruses</title><author><name sortKey="Subbarao, Kanta" sort="Subbarao, Kanta" uniqKey="Subbarao K" first="Kanta" last="Subbarao">Kanta Subbarao</name></author><author><name sortKey="Joseph, Tomy" sort="Joseph, Tomy" uniqKey="Joseph T" first="Tomy" last="Joseph">Tomy Joseph</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:4C7A21E855BC93158567C5E02A824F2912164526</idno><date when="2007" year="2007">2007</date><idno type="doi">10.1038/nri2054</idno><idno type="url">https://api.istex.fr/ark:/67375/GT4-CGS590CN-8/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000761</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000761</idno><idno type="wicri:Area/Istex/Curation">000761</idno><idno type="wicri:Area/Istex/Checkpoint">000405</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000405</idno><idno type="wicri:doubleKey">1474-1733:2007:Subbarao K:scientific:barriers:to</idno><idno type="wicri:source">PMC</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097526</idno><idno type="RBID">PMC:7097526</idno><idno type="wicri:Area/Pmc/Corpus">000240</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000240</idno><idno type="wicri:Area/Pmc/Curation">000240</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000240</idno><idno type="wicri:Area/Pmc/Checkpoint">000B45</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000B45</idno><idno type="wicri:Area/Ncbi/Merge">000215</idno><idno type="wicri:Area/Ncbi/Curation">000215</idno><idno type="wicri:Area/Ncbi/Checkpoint">000215</idno><idno type="wicri:doubleKey">1474-1733:2007:Subbarao K:scientific:barriers:to</idno><idno type="wicri:Area/Main/Merge">001440</idno><idno type="wicri:Area/Main/Curation">001422</idno><idno type="wicri:Area/Main/Exploration">001422</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Scientific barriers to developing vaccines against avian influenza viruses</title><author><name sortKey="Subbarao, Kanta" sort="Subbarao, Kanta" uniqKey="Subbarao K" first="Kanta" last="Subbarao">Kanta Subbarao</name><affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">États-Unis</country><wicri:regionArea>Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892</wicri:regionArea><wicri:noRegion>Maryland 20892</wicri:noRegion></affiliation><affiliation></affiliation></author><author><name sortKey="Joseph, Tomy" sort="Joseph, Tomy" uniqKey="Joseph T" first="Tomy" last="Joseph">Tomy Joseph</name><affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">États-Unis</country><wicri:regionArea>Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892</wicri:regionArea><wicri:noRegion>Maryland 20892</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Nature Reviews Immunology</title><idno type="ISSN">1474-1733</idno><idno type="eISSN">1474-1741</idno><imprint><publisher>Nature Publishing Group</publisher><date when="2007-04">2007-04</date><biblScope unit="vol">7</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="267">267</biblScope><biblScope unit="page" to="278">278</biblScope><date type="Copyright" when="2007">2007</date></imprint><idno type="ISSN">1474-1733</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1474-1733</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="eng">The increasing number of reports of direct transmission of avian influenza viruses to humans underscores the need for control strategies to prevent an influenza pandemic. Vaccination is the key strategy to prevent severe illness and death from pandemic influenza. Despite long-term experience with vaccines against human influenza viruses, researchers face several additional challenges in developing human vaccines against avian influenza viruses. In this Review, we discuss the features of avian influenza viruses, the gaps in our understanding of infections caused by these viruses in humans and of the immune response to them that distinguishes them from human influenza viruses, and the current status of vaccine development.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country></list><tree><country name="États-Unis"><noRegion><name sortKey="Subbarao, Kanta" sort="Subbarao, Kanta" uniqKey="Subbarao K" first="Kanta" last="Subbarao">Kanta Subbarao</name></noRegion><name sortKey="Joseph, Tomy" sort="Joseph, Tomy" uniqKey="Joseph T" first="Tomy" last="Joseph">Tomy Joseph</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001422 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001422 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:4C7A21E855BC93158567C5E02A824F2912164526
|texte= Scientific barriers to developing vaccines against avian influenza viruses
}}
| This area was generated with Dilib version V0.6.33. |  |